Sound Income Strategies’s Vertex Pharmaceuticals VRTX Stock Holding History

Sound Income Strategies’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$256K	Sell	515 -14	-3%	-$6.21K	0.01%	410
2026 Q1	$237K	Buy	529 +9	+2%	+$4.2K	0.01%	373
2025 Q4	$230K	Buy	520 +14	+3%	+$6.03K	0.01%	384
2025 Q3	$210K	Buy	506 +36	+8%	+$15K	0.01%	289
2025 Q2	$209K	Buy	470 +2	+0.4%	+$922	0.01%	272
2025 Q1	$227K	Hold	468	–	–	0.01%	264
2024 Q4	$188K	Hold	468	–	–	0.01%	261
2024 Q3	$218K	Hold	468	–	–	0.01%	236
2024 Q2	$219K	Hold	468	–	–	0.01%	215
2024 Q1	$196K	Hold	468	–	–	0.01%	222
2023 Q4	$190K	Buy	468 +72	+18%	+$26.6K	0.02%	198
2023 Q3	$138K	Hold	396	–	–	0.01%	176
2023 Q2	$139K	Sell	396 -11	-3%	-$3.71K	0.01%	180
2023 Q1	$128K	Buy	407 +11	+3%	+$3.3K	0.01%	176
2022 Q4	$114K	Buy	396 +384	+3,200%	+$117K	0.01%	183
2022 Q3	$3K	Buy	12 +4	+50%	+$1.15K	﹤0.01%	667
2022 Q2	$2K	Hold	8	–	–	﹤0.01%	759
2022 Q1	$2K	Buy	8 +2	+33%	+$475	﹤0.01%	751
2021 Q4	$1K	Hold	6	–	–	﹤0.01%	813
2021 Q3	$1K	Hold	6	–	–	﹤0.01%	794
2021 Q2	$1K	Sell	6 -5	-45%	-$1.05K	﹤0.01%	847
2021 Q1	$2.36K	Buy	11 +5	+83%	+$1.1K	﹤0.01%	742
2020 Q4	$1K	Sell	6 -13	-68%	-$2.98K	﹤0.01%	837
2020 Q3	$5K	Buy	19 +6	+46%	+$1.66K	﹤0.01%	549
2020 Q2	$4K	Buy	+13	New	+$3.52K	﹤0.01%	551
2019 Q1	–	Sell	-5	Closed	-$1K	–	803
2018 Q4	$1K	Hold	5	–	–	﹤0.01%	632
2018 Q3	$1K	Buy	+5	New	+$890	﹤0.01%	655

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Sound Income Strategies's VRTX Position: Q2 2026 in Review

Sound Income Strategies reduced its Vertex Pharmaceuticals (VRTX) stake by 2.6% in Q2 2026, selling an estimated $6.21K and leaving 515 shares worth $256K. The position accounts for 0.01% of the portfolio, ranked #410.

Sound Income Strategies first reported a position in VRTX in Q3 2018 and has held it in 27 quarters since. 1,296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Sound Income Strategies held 515 shares of Vertex Pharmaceuticals worth $256K as of Q2 2026.
Sound Income Strategies sold 14 Vertex Pharmaceuticals shares in Q2 2026, an estimated $6.21K.
Vertex Pharmaceuticals made up 0.01% of Sound Income Strategies's portfolio in Q2 2026, its #410 holding.
Sound Income Strategies first reported a position in Vertex Pharmaceuticals in Q3 2018 and has held it in 27 quarters since.
1,296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.